Clinical trial
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff…
NCT00304408 · Michael E. DeBakey VA Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00304408 |
|---|---|
| Title | Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody |
| Official title | Association Between Clinical Response of Clostridium Difficile Colitis to Treatment and Emergence of Anti-C.Difficile Toxin Antibody |
| Lead sponsor | Michael E. DeBakey VA Medical Center, U.S. Fed |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Study type | Observational |
| Conditions | Clostridium Enterocolitis, Pseudomembranous Colitis, Antibiotic-Associated Colitis |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 17, 2006 |
| Last update posted | Sep 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: